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During obesity, adipose tissue macrophages (ATMs)
adopt a metabolically activated (MMe) phenotype.
However, the functions of MMe macrophages are
poorly understood. Here, we combine proteomic
and functional methods to demonstrate that, in addi-
tion to potentiating inflammation, MMe macro-
phages promote dead adipocyte clearance through
lysosomal exocytosis. We identify NADPH oxidase 2
(NOX2) as a driver of the inflammatory and adipo-
cyte-clearing properties of MMe macrophages and
show that, compared to wild-type, Nox2/ mice
exhibit a time-dependent metabolic phenotype dur-
ing diet-induced obesity. After 8 weeks of high-fat
feeding, Nox2/ mice exhibit attenuated ATM
inflammation andmildly improved glucose tolerance.
After 16 weeks of high-fat feeding, Nox2/ mice
develop severe insulin resistance, hepatosteatosis,
and visceral lipoatrophy characterized by dead
adipocyte accumulation and defective ATM lyso-
somal exocytosis, a phenotype reproduced in
myeloid cell-specific Nox2/ mice. Collectively,
our findings suggest that MMe macrophages
perform detrimental and beneficial functions whose
contribution to metabolic phenotypes during obesity
is determined by disease progression.
INTRODUCTION
During obesity, macrophages accumulate in visceral adipose
tissue, where they promote chronic low-grade inflammation
(Weisberg et al., 2003; Xu et al., 2003). It is well accepted that
this inflammation is causally associated with insulin resistance
in mice. Inhibiting several pathways that drive inflammatory
signaling and/or production in macrophages improves insulin
sensitivity during obesity (Han et al., 2013; Patsouris et al.,
2008; Saberi et al., 2009; Wei et al., 2016).
In addition to producing inflammatory cytokines, adipose tis-
sue macrophages (ATMs) have also been postulated to perform
beneficial functions during diet-induced obesity (DIO) (Fitzgib-
bons and Czech, 2016). They internalize excess free fatty acids
(FFAs) released by insulin-resistant adipocytes, thereby buff-
ering metabolic tissues from the damage caused by ectopic
accumulation of saturated FFAs. They also clear dead adipo-
cytes that accumulate during prolonged obesity when adipose
tissue expands enough to produce hypoxia (Strissel et al.,
2007; Sun et al., 2011). The clearance of these dead adipocytes
promotes adipocyte turnover and maintains adipose tissue
health during nutrient excess.
The diverse functions of macrophages, such as those
described earlier, have often been conceptualized through an
M1 andM2 paradigm (Gordon and Taylor, 2005). TheM1 pheno-
type is caused by Th1 mediators such as lipopolysaccharide
(LPS) and interferon gamma (IFNg) and is characterized by
increased production of pro-inflammatory cytokines, while the
M2 phenotype is driven by Th2 mediators (e.g., interleukin-4
[IL-4]), which activates expression of immunosuppressive fac-
tors that promote macrophage clearance of dead cells and tis-
sue remodeling (Odegaard et al., 2007). Although this M1/M2
paradigm has been a useful construct for understanding macro-
phage heterogeneity, studies suggest that it cannot adequately
describe the functions of ATMs during obesity.
Studies from Xu et al., (2013) showed that macrophages from
obese mice induce lysosomal and lipid metabolism pathways,
raising the possibility that these pathways might help macro-
phages to clear dead adipocytes and their large FFA reservoirs.
Moreover, studies from our laboratory showed that saturated
FFAs produce a pro-inflammatory, metabolically activated
(MMe) macrophage phenotype that is mechanistically distinct
from M1 or M2 activation (Kratz et al., 2014). Although we
showed thatMMemacrophages accumulate in visceral and sub-
cutaneous adipose tissue of obese humans and mice, their roles
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in regulating macrophage inflammation, function, and insulin
sensitivity have not been explored.
Here we combine proteomic and functional analyses with
genetic models and dietary interventions to investigate the roles
of MMemacrophages in DIO. We show that metabolic activation
of macrophages induces inflammatory cytokine production
(a detrimental function) and lysosomal exocytosis to dead adipo-
cytes (a beneficial function). We identify NADPH oxidase 2
(NOX2) as a key regulator of the inflammatory cytokine expres-
sion and lysosomal exocytosis in MMe macrophages and
show that ablating Nox2 both improves and worsens the meta-
bolic phenotype during DIO, depending on the duration of
high-fat feeding. Collectively, our findings underscore the dy-
namic functions of ATMs during DIO and demonstrate the impor-
tance of the MMe phenotype in regulating these functions and
their metabolic consequences.
RESULTS
Metabolic Activation InducesMacrophage Inflammation
and Lysosomal Exocytosis In Vitro and In Vivo
We previously showed that saturated FFAs produce macro-
phage inflammation via an MMe pathway that is mechanistically
distinct from the classically activated M1 phenotype induced by
bacterial challenge (Kratz et al., 2014). Although we showed that
these MMemacrophages are present in adipose tissue of obese
humans and mice, their functions in DIO and insulin resistance
are poorly understood.
To interrogate how metabolic activation might alter macro-
phage function, we produced pro-inflammatory MMe macro-
phages by treating murine bone marrow-derived macrophages
(BMDMs) with glucose, insulin, and palmitate (Figure 1A) and
performed plasma membrane proteomics. We focused on
plasma membrane proteins because they mediate a variety of
important macrophage functions, including phagocytosis, cell
migration, and antigen presentation.
Mass spectrometric analysis of the plasma membrane identi-
fied 664 proteins in M0 (unstimulated) and MMe macrophages.
Statistical analysis with the t test and G test identified 176 pro-
teins that were differentially abundant (false discovery rate
[FDR] < 0.05) in MMe versus M0 macrophages (Figure 1B).
Gene ontology analysis of proteins induced in MMe macro-
phages identified enrichments in several annotations expected
for a cell surface proteome (i.e., plasma membrane, membrane
raft, and extracellular matrix) (Figure 1C), suggesting that our
methods for isolating plasma membrane proteins were robust.
Moreover, we observed increased levels of MMe-associated
proteins (PLIN2 and P62), but not M1-associated proteins
(CD40 and STAT1), that we previously identified in proteomic an-
alyses of human MMe and M1 macrophages (Figure S1) (Kratz
et al., 2014).
Unexpectedly, plasma membrane proteins induced in MMe
macrophages were enriched in lysosomal membrane proteins
(p = 106) (Figure 1C; Table S1), and this enrichment was specific
to the MMe phenotype, because they were not observed in M1
macrophages (Figure 1C). To confirm these observations using
an alternative approach, we quantified cell surface LAMP1 and
LAMP2 levels onM0,MMe, andM1macrophages by flowcytom-
etry. Consistent with our proteomics data, we found that LAMP1
and LAMP2were induced on the cell surface ofMMe, but notM1,
macrophages (Figure 1D; Figure S1). Because lysosomal mem-
brane proteins appear on the cell surface during lysosomal
exocytosis,when lysosomal andplasmamembranes fuse (Rodrı´-
guez et al., 1997), these findings suggest that metabolic activa-
tion induces macrophages to exocytose their lysosomes.
Previous studies showed that lysosomal exocytosis bymacro-
phages is required for them to clear dead adipocytes (Haka et al.,
2016). Because macrophages (20 mm diameter) are much
smaller than adipocytes (120 mm diameter), they cannot clear
dead adipocytes through a traditional phagocytosis mechanism.
Instead, the macrophages form a tight attachment (a lysosomal
synapse) on the dead adipocyte. They acidify the contact region
using the plasma membrane proton pumping V-ATPase and
secrete lysosomal contents into the lysosomal synapse. The
lysosomal lipases in the acidic milieu liberate FFAs that are sub-
sequently internalized by macrophages, leading to foam cell
formation.
Because FFAs are required for metabolic activation, and dead
adipocytes are an abundant reservoir of FFA, we hypothesized
that dead adipocytes could induce the inflammation and lyso-
somal exocytosis associated with the MMe phenotype. To test
this hypothesis, we treated unstimulated BMDMs with media
conditioned by live or apoptotic 3T3-L1 adipocytes and
measured inflammatory cytokine expression by qRT-PCR and
quantified lysosomal exocytosis by staining for cell surface
LAMP1 and LAMP2.
We found that media from apoptotic adipocytes coordinately
induced the expression of Il1b and Il6 (Figure 1E) and the appear-
ance of cell surface LAMP1 and LAMP2 on macrophages (Fig-
ure 1F). The effects on cytokines and lysosomal exocytosis
were specific to apoptotic adipocytes, because media from
live 3T3-L1 adipocytes or apoptotic neutrophils (a dead cell
without FFA) were incapable of inducing these changes (Figures
1E and 1F). Thus, dead adipocytes release factors that induce
the inflammation and lysosomal exocytosis characteristic of
MMe macrophages.
Our previous studies showed that ATMs from obese mice
adopt an MMe phenotype (Kratz et al., 2014). We therefore
reasoned that ATMs from obese mice would also show coordi-
nated induction of cytokine expression and lysosomal exocy-
tosis. To test this, we fed C57BL/6 mice a low-fat diet (LFD) or
45% high-fat diet (HFD) for 16 weeks, isolated ATMs (Figure 1G),
confirmed their purity based on CD11c and F4/80 staining
(98.1%) (Figure 1H), and assessed cytokine expression by
qRT-PCR and cell surface lysosomal membrane protein levels
by mass spectrometry.
Consistent with previous findings, ATMs from obese mice
were characterized by elevated Tnfa, Il6, and Il1b expression
(Figure 1I). Moreover, plasma membrane proteins elevated in
ATMs from obese mice (relative to lean mice) were significantly
enriched for lysosomal membrane proteins (p = 107). Indeed,
10 lysosomal membrane proteins were induced on the cell sur-
face of ATMs from obese mice (Figures 1J and 1K; Table S1),
6 of which (LAMP2, ATP6V1B2, ATP6V1A, AHNAK, NPC1, and
ANXA2) were also induced on the cell surface of MMe macro-
phages in vitro.
3150 Cell Reports 20, 3149–3161, September 26, 2017
TLR2, NOX2, and MYD88 Coordinately Regulate
Inflammation and Lysosomal Exocytosis in MMe
Macrophages
What signaling pathways regulate cytokine expression and lyso-
somal exocytosis inMMemacrophages? To begin to answer this
question, we searched the literature for proteins known to
mediate macrophage responses to FFAs, the driver of the
MMe phenotype. We focused on toll-like receptor (TLR) 2,
NOX2, MYD88, and TLR4 because previous studies showed
that these proteins are required for palmitate-induced inflamma-
tion and/or endoplasmic reticulum (ER) stress in macrophages
(Kratz et al., 2014; Robblee et al., 2016; Seimon et al., 2010).
We first investigated the effects of these knockouts on in-
flammatory cytokine expression. We found that ablating Nox2
(Gp91 subunit), Tlr2, Myd88, or Tlr4 attenuated Il6 and Il1b
levels in MMe macrophages (Figure 2A; Figure S2). The anti-
inflammatory effect of ablating Nox2 or Tlr2 was specific to
MMe macrophages, because cytokine expression in M1 mac-
rophages was unaffected (Figure 2A). In contrast, ablating
Tlr4 or Myd88, an adaptor protein used by most TLRs to
activate nuclear factor kB (NF-kB) (Akira et al., 2001), lowered
inflammatory cytokine expression in both MMe and M1
macrophages (Figure 2A; Figure S2). Altogether, these studies
identified TLR2, NOX2, MYD88, and TLR4 as regulators of
inflammatory cytokine expression in MMe macrophages
and further demonstrated that distinct signaling pathways regu-
late inflammatory cytokine expression in MMe and M1
macrophages.
Figure 1. MMe Macrophages Overexpress Cytokines and Accumulate Cell Surface Lysosomal Membrane Proteins In Vitro and In Vivo
(A–D) BMDMs (M0) were metabolically activated (MMe) or classically activated (M1). (A) Inflammatory cytokine expression levels. (B) Plasma membrane pro-
teomics analysis with the t test and G test identifies proteins induced (yellow) and suppressed (blue) on the cell surface of MMe macrophages (relative to M0).
(C) Gene ontology analysis of plasmamembrane proteins elevated on the cell surface of MMemacrophages (relative to M0). Relative abundances of proteins are
presented as a heatmap. (D) Flow cytometric quantification of cell surface LAMP1 and LAMP2.
(E and F) BMDMs (M0) were treated with conditioned media collected from 3T3-L1 adipocytes (live or apoptotic) or apoptotic neutrophils (polymorphonuclear
neutrophils [PMN]). (E) Inflammatory cytokine expression levels. (F) Flow cytometric quantification of cell surface LAMP1 and LAMP2.
(G–J) Analysis of ATMs fromC57BL/6mice fed a low-fat (LFD) or high-fat diet (HFD) for 16 weeks. (G) ATMswere isolated from the stromal vascular fraction (SVC)
using anti-CD11b-coupled magnetic beads. ATM purity and recover were confirmed by staining for CD11b in the purified ATMs, SVC, and flowthrough (FT).
(H) ATM purity was assessed by staining for CD11c and F4/80. (I) Inflammatory cytokine expression levels. (J) Heatmap of the relative abundance of cell surface
lysosomal membrane proteins.
(K) A comparison of cell surface levels of LAMP2, NPC1, and ATP6v1a in vitro and in vivo; proteins were quantified by mass spectrometry.
Results are mean ± SEM; n = 3–6, *p < 0.05 Student’s t test, ##p < 0.05 Student’s t test and G > 1.5 G test. See also Figure S1 and Table S1.
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We further investigated the effects of these knockouts on lyso-
somal exocytosis. To this end, we used a more physiologically
relevant co-culture assay (Haka et al., 2016) that quantifies
(1) the delivery of lysosomal contents from macrophages to
apoptotic 3T3-L1 adipocytes and (2) the subsequent accumula-
tion of adipocyte-derived lipids in the macrophage (Figure 2B).
As a control, macrophages were co-incubated with live adipo-
cytes, demonstrating the specificity of these processes to
apoptotic adipocytes (Figure 2B).
We found that lysosomal exocytosis to apoptotic adipocytes
was significantly impaired in Nox2/, Tlr2/, and Myd88/
macrophages (Figure 2C). Moreover, Nox2/, Tlr2/, and
Myd88/macrophagesaccumulated fewer lipids fromapoptotic
adipocytes (Figure 2C), perhaps due to their inability to deliver
lysosomal lipases to mobilize FFAs from the adipocyte lipid
droplet. Consistent with this interpretation, the extent of macro-
phage lipid accumulation was strongly and positively correlated
(R2= 0.94, p< 0.0001) to theamountof lysosomal exocytosis (Fig-
ure 2D). Moreover, Nox2/, Tlr2/, and Myd88/ macro-
phages were not defective in their ability to internalize palmitate
(Figure 2E), one of the major FFAs liberated during lipolysis from
adipocytes.
Lysosomal exocytosis to apoptotic adipocytes was not
impaired in Tlr4/ macrophages (Figure S2), even though this
knockout suppressed inflammatory cytokine expression. These
findings suggest that the defective lysosomal exocytosis
observed in Tlr2/, Nox2/, and Myd88/ macrophages
was not reliant upon the suppression of inflammatory cytokines.
Consistent with this hypothesis, supplementing Nox2/macro-
phages with tumor necrosis factor alpha (TNF-a), a key cytokine
produced by ATMs, could not rescue the defect in lysosomal
exocytosis (Figure 2F).
ATM Inflammation Precedes Visceral Fat Adipocyte
Death during DIO
Our in vitro findings suggest that MMe macrophages might play
complex roles during DIO. However, MMemacrophages overex-
press inflammatory cytokines, which could promote insulin
resistance (Chawla et al., 2011; Olefsky and Glass, 2010). How-






































































































































































































































































Figure 2. TLR2, NOX2, and MYD88 Coordinately Regulate Inflammatory Cytokine Expression and Lysosomal Exocytosis in MMe
Macrophages
(A) Inflammatory cytokine expression in metabolically activated (MMe) macrophages and classically activated (M1) BMDMs made from wild-type (WT), TLR2-
deficient (Tlr2/), NOX2-deficient (Gp91/), or MYD88-deficient (Myd88/) mice. Levels are expressed relative to M0 for each genotype.
(B–D) Quantification of macrophage lysosomal exocytosis and lipid uptake from live or apoptotic 3T3-L1 adipocytes. (B) Schematic of the assay: (i) macrophage
lysosomal exocytosis was quantified as the capture of previously endocytosed biotin-fluorescein-dextran (green) on the cell surface of streptavidin-labeled
apoptotic adipocytes, and (ii) macrophage lipid uptake was quantified as the amount of LipidTOX signal (red) inside Alexa 444-CtB-labeledmacrophages (green).
Scale bar, 20 mm. (C) Quantification of lysosomal exocytosis and lipid uptake by WT, Tlr2/, Gp91/, or Myd88/ BMDMs. (D) Relationship between
macrophage lipid uptake and lysosomal exocytosis.
(E) Relative uptake of palmitate from the media by WT, Tlr2/, Gp91/, or Myd88/ BMDMs.
(F) Lysosomal exocytosis by Nox2/ macrophages pre-treated with TNF-a.
Results are mean ± SEM; n = 3–12, *p < 0.05 Student’s t test. See also Figure S2.
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dead adipocytes, which could limit insulin resistance by main-
taining adipose tissue health and protecting against ectopic lipid
deposition in the liver (Shulman, 2014; Strissel et al., 2007; Sun
et al., 2011). Because these potentially detrimental and benefi-
cial properties of MMe macrophages are coordinately regulated
by TLR2, NOX2, and MYD88, we reasoned that interpreting the
metabolic phenotypes of mice deficient in one or more of these
proteins might be challenging.
To help facilitate interpretation, we first determined whether
ATM inflammation and adipocyte death (and hence the need
for dead adipocyte clearance) occurred at different time points
during DIO. Previous studies showed that ATM inflammation
might be an early and persistent event, while adipocyte death
may predominantly occur after prolonged high-fat feeding
when adipose tissue becomes hypoxic (Figure 3A) (Strissel
et al., 2007). However, these studies were performed in mice
fed a 60% HFD, and our studies used the 45% HFD. To better
understand the timing of these events and to establish reproduc-
ible conditions to investigate the effects of our knockouts on
these processes in vivo, we studied adipose tissue biology in
wild-type C57BL/6 mice fed an LFD or 45% for 8 and 16 weeks
(Figure 3B).
Figure 3. ATM Inflammation Precedes Visceral Fat Adipocyte Death during DIO
Wild-type C57BL/6 mice were fed a low-fat diet (LFD) or 45% high-fat diet (HFD) for 8 or 16 weeks.
(A) A model for the timing of ATM inflammation and epididymal fat death during DIO.
(B) Body weight gain.
(C) mRNA expression of inflammatory cytokines and lipid metabolism genes in purified ATMs.
(D) Hif1a mRNA levels in epididymal fat (a marker of hypoxia).
(E) Caspase-3 (CASP3) activity levels in epididymal fat.
(F) Epididymal fat was stained with antibodies against PLIN2 (red, identifies adipocytes), MAC2 (green, identifiesmacrophages), and DAPI (blue, identifies nuclei).
Macrophages in crown-like structures (CLSs, arrow) were quantified by microscopy and standardized per unit area.
(G) H&E staining of liver and quantification of liver triglyceride (TG) levels.
Results are mean ± SEM; n = 5–15, *p < 0.05 Student’s t test. See also Figures S3 and S4.
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Eight weeks of high-fat feeding was sufficient to induce the
MMe phenotype in ATMs characterized by increased inflamma-
tory cytokines (Tnfa, Il6, and Il1b) and genes involved in lipid
metabolism (Plin2, Abca1, and Cd36) (Figure 3C). Despite the
presence of ATM inflammation, several lines of evidence indi-
cated that epididymal fat health in obese mice was not signifi-
cantly compromised at this timepoint. First, adipose tissue levels
ofHif1awere not elevated (Figure 3D), suggesting that hypoxia, a
key driver of adipocyte death (Wang et al., 1995), had not yet
occurred. Second, adipose tissue caspase-3 activity, a marker
of apoptosis (Nicholsonet al., 1995),wasnot elevated (Figure 3E).
Third, the number of crown-like structures, an indicator of adipo-
cyte death (Murano et al., 2008), was unchanged (Figure 3F; Fig-
ure S3). Finally, ectopic fat deposition in the liver, which has been
associated with adipocyte death in visceral fat (Strissel et al.,
2007), was undetectable (Figure 3G; Figure S4).
Although ATMs still overexpressed the cytokines and lipid
metabolism genes characteristic of MMe macrophages
following 16 weeks of high-fat feeding (Figure 3C), the state of
epididymal fat health was substantially different at this time
point. Adipose tissueHif1a levels were elevated (Figure 3D), sug-
gesting that the tissue was hypoxic. Moreover, adipose tissue
caspase-3 activity and crown-like structures were markedly
increased (Figures 3E and 3F; Figure S3), indicating the presence
of apoptotic adipocytes. Consistent with the deterioration of
epididymal fat health and increased FFA release, the MMe
phenotype was more pronounced at this time point, particularly
with respect to the lipid metabolism genes (Figure 3C). More-
over, ectopic fat deposition in the liver was detectable in obese
mice (Figure 3G; Figure S4), and this deposition could not be ex-
plained by changes in genes involved in triglyceride (TG) synthe-
sis (Fas1,Acc1, and Srebp1) or fatty acidmetabolism (Ppara and
Cpt1a) in the liver (Figure S4).
These findings suggest that while MMe ATMs are present at
both 8 and 16 weeks of 45% high-fat feeding, adipocyte death,
and hence the requirement for macrophages to clear dead adi-
pocytes, may only be an important consideration after 16 weeks
of high-fat feeding.
Nox2/ Mice Have Improved ATM Inflammation and
Glucose Tolerance after 8 Weeks of High-Fat Feeding
Our identification of NOX2, TLR2, and MYD88 as drivers of cyto-
kine expression and lysosomal exocytosis inMMemacrophages
provided an opportunity to inhibit these processes in vivo and
assess effects on obesity-associated insulin resistance. We
focused our initial studies on Nox2/ mice because NOX2 is
predominantly expressed by phagocytic cells, including macro-
phages and neutrophils (Bedard and Krause, 2007).
We began by interrogating the metabolic phenotypes of
Nox2/ mice following 8 weeks of high-fat feeding. Because
ATM inflammation was present at this time point, but adipocyte
apoptosis had not yet occurred (Figure 3), we hypothesized that
the anti-inflammatory effect of Nox2/ would predominate and
protection from metabolic derailments during DIO would be
observed at this early time point. This hypothesis makes several
predictions.
First, ablating Nox2 should attenuate ATM inflammation.
Although Nox2/ mice fed the HFD were heavier than wild-
type mice (Figure 4A), ATMs isolated from visceral fat were sub-
stantially less inflamed, as evidenced by decreased expression
of Tnfa, Il6, and Il1b (Figure 4B). Because NOX2 drives inflamma-
tory cytokine expression inMMe, but not M1,macrophages (Fig-
ure 2), these findings reinforce the notion that ATMs are inflamed
via an MMe pathway in vivo (Kratz et al., 2014).
Second, ablating Nox2 should not increase the number of
dead adipocytes.Nox2/mice showed no differences in adipo-
cyte death indicators; Hif1a levels, caspase-3 activity, and the
number crown-like structures were unchanged, and ectopic fat
accumulation in the liver was only minimally and insignificantly
increased in Nox2/ mice relative to wild-type mice fed the
HFD (Figures 4C–4F; Figures S3 and S4). Moreover, none of
these adipocyte death indicators were elevated in obese relative
to lean mice, irrespective of genotype (Figures 4C–4F), which is
consistent with our findings that 8 weeks of 45% HFD is insuffi-
cient to induce adipocyte death (Figure 3).
Third, this hypothesis predicts that Nox2/ mice should
demonstrate improved metabolic parameters. Nox2/ mice
fed the HFD had lower fasting glucose levels (Figure 4G) and
improved glucose tolerance (Figure 4H). However, fasting insulin
levels and insulin tolerance remained unchanged (Figures 4G
and 4I), perhaps due to the increased body weight, the mild
hepatosteatosis, and the increased number of ATMs in Nox2/
mice (Figure S5), all of which would limit the anti-inflammatory
effect of the knockout.
Altogether, these findings provide further evidence that ATMs
are inflamed via anMMe pathway in vivo and further suggest that
inhibiting inflammatory cytokine expression in MMe macro-
phages (by ablating Nox2) protects against metabolic dysfunc-
tion following 8 weeks of high-fat feeding.
Nox2/ Mice Develop Severe Visceral Lipoatrophy,
Hepatosteatosis, and Insulin Resistance following 16
Weeks of HFD
Next, we investigated the metabolic phenotypes of Nox2/
mice fed a HFD for 16 weeks. Because ATM inflammation and
adipocyte death were both present at this time point (Figure 3),
and ablating Nox2 attenuated metabolic activation and lyso-
some secretion in response to dead adipocytes (Figure 2), we
hypothesized that Nox2/ mice might exhibit a more complex
phenotype at this later time point. To explore this, we character-
ized the adipose tissue, liver, and metabolic parameters of
Nox2/ mice fed the HFD for 16 weeks.
The protection observed inNox2/mice following 8 weeks of
HFD was reversed after prolonged high-fat feeding. Nox2/
mice fed a HFD for 16 weeks were more obese, hyperglycemic,
hyperinsulinemic, and insulin resistant than wild-type controls
(Figures 5A–5D). Nox2/ mice retained glucose tolerance, but
they required higher levels of insulin production to maintain
glucose homeostasis (Figure 5C).
An examination of the epididymal fat in Nox2/ mice fed the
HFD for 16 weeks revealed marked increases in the number of
crown-like structures (Figure 5E; Figure S3) and caspase-3 activ-
ity (Figure 5F) relative to control mice, suggesting a higher accu-
mulation of dead adipocytes. The extent of this adipocyte death
was substantial given that Nox2/ mice fed the HFD had less
epididymal fat mass than wild-type mice (Figure 5G), despite
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being more obese (Figure 5A). In contrast, Nox2/ mice had
more epididymal fat than wild-type mice following 8 weeks of
HFD (Figure 5G). These findings suggest that Nox2/ mice are
capable of expanding their epididymal fat mass during early
DIO but that they cannot sustain it during prolonged exposure
to the HFD.
Despite the increased number of dead adipocytes in Nox2/
mice, which should induce macrophage inflammation (Figure 1),
ATM expression of Tnfa, Il6, and Il1b was similar to that of wild-
type mice (Figure 5H). Thus, it is likely that the anti-inflammatory
effect of ablating Nox2was still present at 16 weeks but masked
by the hyper-inflammatory environment produced by the dead
adipocytes.
Consistent with the deterioration of epididymal fat health and
mass at 16 weeks of HFD, Nox2/ mice displayed severe hep-
atosteatosis, characterized by increased hepatic TG mass and
liver weight (Figures 5I–5K; Figure S4), This hepatosteatosis
could not be explained by changes in the expression of liver
genes involved in TG synthesis (Fas1, Acc1, and Srebp1) or fatty
acid metabolism (Ppara and Cpt1a) (Figure 5L).
Altogether, these studies showed that Nox2/ mice develop
severe late-onset adipocyte death, hepatosteatosis, and insulin
resistance. Because Nox2/ mice are more obese than their
wild-type counterparts, we explored the possibility that these
late-onset effects were due to excess body mass. To test this,
we fed wild-type mice a HFD until their average body weight
Figure 4. Nox2/ Mice Have Improved ATM Inflammation and Glucose Tolerance after 8 Weeks of HFD
Wild-type (WT) and Gp91/ mice were fed a low-fat diet (LFD) or 45% high-fat diet (HFD) for 8 weeks.
(A) Body weight gain.
(B) Inflammatory cytokine expression in purified ATMs.
(C) Hif1a mRNA levels in epididymal fat (a marker of hypoxia).
(D) Epididymal fat was stained with antibodies against PLIN2 (red, identifies adipocytes), MAC2 (green, identifiesmacrophages), andDAPI (blue, identifies nuclei).
Macrophages in crown-like structures (CLSs, arrow) were quantified by microscopy and standardized per unit area.
(E) Caspase-3 (CASP3) activity levels in epididymal fat.
(F) H&E staining of liver and quantification of liver triglyceride (TG) levels.
(G) Fasting blood glucose levels and serum insulin levels.
(H and I) Glucose tolerance (H) and insulin tolerance (I) tests inWT andGp91/mice fed the HFD. Glucose tolerance and insulin tolerance were assessed by area
under the curve (AUC) analysis.
Results are mean ± SEM; n = 5–15, *p < 0.05 Student’s t test. See also Figures S3–S5.
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matchedNox2/mice at 16 weeks (wild-type match) and quan-
tified key aspects of the metabolic phenotype.
We found that wild-type-match mice could not mimic the late-
onset dead adipocyte accumulation, hepatosteatosis, and insu-
lin resistance observed inNox2/mice (Figures S3, S4, and S6),
suggesting that these metabolic abnormalities were not driven
by the increased body weight ofNox2/mice fed the HFD. Liver
TGs and fasting glucose levels were not correlated to body
weight in wild-type and Nox2/ mice fed the HFD (Figures 5M
and 5N). In contrast, these parameters were significantly and
positively correlated to the extent of adipocyte death in epidid-
ymal fat, as determined by caspase-3 activity (Figures 5M and
5N). Thus, the inability of Nox2/ mice to sustain their epidid-
ymal fat may help to explain the late-onset hepatosteatosis
and metabolic defects observed in these mice.
Dead Adipocyte Accumulation Is Associated with
Defective Lysosomal Exocytosis by Nox2/ ATMs
In principle, the number of dead adipocytes observed in vivo is
determined both by the rate of death and the rate of clearance
(Figure 6A); the latter process, which is mediated by ATMs, has
not been the subject of intensive study. Because Nox2/ mac-
rophages exhibited defective lysosomal exocytosis and clear-
ance of apoptotic adipocytes in vitro (Figures 1 and 2), we
reasoned that defective dead adipocyte clearance by ATMs
might help to explain the late-onset accumulation of dead adipo-
cytes. We used three approaches to test this hypothesis.
First, we investigated whether drivers of adipocyte death were
elevated in Nox2/ mice. Adipocyte apoptosis can be caused
by hypoxia and/or inflammation (Sun et al., 2011), both of which
increase as adipose tissue expands during obesity. Neither of
Figure 5. Nox2/ Mice Develop Severe Visceral Lipoatrophy, Hepatosteatosis, and Insulin Resistance following 16 Weeks of HFD
Wild-type (WT) and Gp91/ mice were fed a low-fat diet (LFD) or 45% high-fat diet (HFD) for 16 weeks.
(A) Body weight gain.
(B) Fasting blood glucose levels and serum insulin levels.
(C and D) Glucose tolerance test (GTT) (C) and insulin tolerance test (ITT) (D) in WT and Gp91/mice fed the HFD. Insulin levels during the GTT are shown in the
inset. Glucose tolerance and insulin tolerance were assessed by area under the curve (AUC) analysis.
(E) Epididymal fat was stained with antibodies against PLIN2 (red, identifies adipocytes), MAC2 (green, identifiesmacrophages), and DAPI (blue, identifies nuclei).
Macrophages in crown-like structures (CLSs, arrow) were quantified by microscopy and standardized per unit area.
(F) Caspase-3 (CASP3) activity levels in epididymal fat.
(G) Epididymal fat mass following in WT and Gp91/ mice following 8 and 16 weeks of HFD.
(H) Inflammatory cytokine expression in purified ATMs.
(I) H&E staining of liver.
(J) Liver triglyceride (TG) levels.
(K) Liver weight.
(L) Hepatic expression of genes involved in TG synthesis and metabolism in mice fed the HFD.
(M and N) Linear regression analysis of body weight or epididymal fat caspase-3 activity versus liver TGs (M) and fasting glucose levels (N).
Results are mean ± SEM; n = 5–15, *p < 0.05 Student’s t test. See also Figures S3–S6.
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thesemechanisms are a likely cause of dead adipocyte accumu-
lation in Nox2/ mice, because adipose tissue levels of Hif1a
(hypoxia marker) and Tnfa and Il1b (pro-inflammatory markers)
were unchanged after 16 weeks of high-fat feeding compared
towild-typemice (Figures 6B and 6C). Moreover, ATM inflamma-
tion (Figure 5) and ATM number (Figure S5) were not significantly
different between wild-type and Nox2/ mice fed the HFD.
Second, we determined whether ATMs from Nox2/ mice
had lower cell surface levels of lysosomal membrane proteins,
the hallmark of lysosomal exocytosis (Rodrı´guez et al., 1997).
We isolated ATMs from HFD-fed wild-type and Nox2/ mice
and interrogated them by plasma membrane proteomics. This
analysis identified 8 lysosomal membrane proteins on the cell
surface of wild-type ATMs, all of which were lower on the cell
surface of ATMs from Nox2/ mice (Figures 6D and 6E; Table
S1). The decreased levels of lysosomal membrane proteins on
Nox2/ ATMs were likely underestimated given that Nox2/
mice had significantly more dead adipocytes, which should
stimulate lysosomal exocytosis (Figures 1 and 2). These findings
suggest that ATMs from Nox2/ mice exhibit impaired lyso-
somal exocytosis in vivo.
Third, we determined whether ablating Nox2 in myeloid cells
specifically could reproduce the late-onset accumulation of
dead adipocytes and associated metabolic derailments. We
crossed Nox2fl/fl mice with LysM-Cre+/ mice to generate
myeloid cell-specific, Nox2-deficient mice (Nox2fl/flLysM-
Cre+/) and littermate controls (Nox2fl/flLysM-Cre/). After vali-
dating Nox2 knockout in ATMs (Figure S7), we examined the
metabolic phenotypes of these mice following prolonged high-
fat feeding.
Myeloid cell-specific ablation ofNox2mimicked the late-onset
accumulation of dead adipocytes in the absence of increased
hypoxia or adipose tissue inflammation (Figures 7A–7D; Fig-
ure S3), hepatosteatosis and increased liver weight (Figures 7E
and 7F; Figure S4), obesity (Figure 7G), hyperglycemia (Fig-
ure 7H), and hyperinsulinemia (Figure 7I) phenotypes of the
whole-animal knockout. The stronger increase in the number
of crown-like structures in the LysM-Cre model relative to the
global knockout was due to the presence of fewer crown-like
structures in LysM-Cre/ control mice, which likely reflects
the variability in the appearance of crown-like structures in vivo.
These findings suggest that the accumulation of dead adipo-
cytes and the associated metabolic dysfunction are driven by
the loss of Nox2 in myeloid cells, not an unanticipated effect in
adipocytes.
DISCUSSION
Accumulating evidence suggests that ATMs perform both detri-
mental and beneficial functions during obesity. They produce in-
flammatory cytokines that promote insulin resistance (Chawla
et al., 2011; Olefsky and Glass, 2010). They also might protect
metabolic tissues from the deleterious effects of excess FFAs
and contribute to adipose tissue homeostasis by clearing dead
adipocytes. Traditionally, these diverse functions have been
attributed to distinct ATM populations; the detrimental functions
have been associated with M1-like macrophages, which may
predominate during early DIO (Lumeng et al., 2007), while the
beneficial functions have been ascribed to M2-like macro-
phages, which may accumulate during prolonged DIO (Shaul
et al., 2010).
Here we provide evidence that inflammatory cytokine produc-
tion and dead adipocyte clearance are functional properties of a
single MMe macrophage phenotype that is present during early
and late DIO. We further show that inflammatory signaling
through NOX2, TLR2, and MYD88 coordinately regulates both
the detrimental and the beneficial functions of MMe macro-
phages. Accordingly, ablating Nox2 produces a complex meta-
bolic phenotype determined by the duration of high-fat feeding,
which in turn highlights the relative importance of macrophage
Figure 6. ATMs from Obese Nox2/ Mice
Exhibit Lower Levels of Lysosomal Mem-
brane Proteins on the Cell Surface
Wild-type (WT) and Gp91/ mice were fed a low-
fat diet (LFD) or 45% high-fat diet (HFD) for
16 weeks.
(A) A model for the determinants of dead adipocyte
number in vivo.
(B)Hif1amRNA levels in epididymal fat (amarker of
hypoxia).
(C) Inflammatory cytokine expression levels in
epididymal fat.
(D and E) ATMs were purified from WT and
Gp91/ mice and interrogated by plasma mem-
brane proteomics. (D) Heatmap of the relative
abundance of cell surface lysosomal membrane
proteins. (E) Examples of several lysosomal mem-
brane proteins on the cell surface of ATMs; pro-
teins were quantified by mass spectrometry.
Results are mean ± SEM; n = 2–5, #p < 0.05 G test.
See also Table S1.
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inflammation and dead adipocyte clearance during the progres-
sion of obesity.
After 8 weeks of HFD, wild-type mice exhibited ATM inflam-
mation in the absence of adipose tissue hypoxia and adipocyte
death, indicating a low need for dead adipocyte clearance at
this time point. Accordingly, the anti-inflammatory benefit of
ablating Nox2 was observed without exposing the costs asso-
ciated with impaired dead adipocyte clearance. Nox2/ mice
had attenuated ATM inflammation and exhibited improvements
in fasting glucose and glucose tolerance, even though mice
were more obese, had more ATMs in epididymal fat, and
were trending to hepatosteatosis—all of which should exacer-
bate metabolic dysfunction during DIO. Because ablating
Nox2 inhibits inflammation in MMe macrophages, but not
M1 macrophages, our findings further underscore the impor-
tance of metabolic activation in producing ATM inflammation
in obesity.
In contrast, after 16 weeks of HFD, we found that dead adipo-
cytes accumulated in epididymal fat of wild-type mice, and this
accumulation was significantly exacerbated in Nox2/ mice,
suggesting that the costs associated with impaired dead adipo-
cyte clearance were evident at this time point.
Three lines of evidence suggest that this late-onset dead
adipocyte accumulation in Nox2/ mice was due to impaired
clearance by ATMs. First, we showed that inflammation and hyp-
oxia, the main drivers of adipocyte death, were not increased in
Nox2/ mice relative to wild-type mice. Second, we showed
that ablating Nox2 interfered with dead adipocyte clearance
through lysosomal exocytosis in vitro and further showed that
Nox2/ ATMs had impaired lysosomal exocytosis in vivo. Third,
we showed that mice lacking Nox2 in myeloid cells specifically
reproduced this late-onset phenotype. Although neutrophils
are also targeted by the LysM-Cre system (Clausen et al.,
1999), ATMs are the most abundant cell type in adipose tissue
and form the adipocyte-clearing crown-like structures during
DIO. It is therefore unlikely that neutrophils significantly
contribute to the impaired adipocyte clearance observed in vivo.
However, because neutrophils promote insulin resistance during
DIO (Talukdar et al., 2012), we cannot ignore their potential
contribution to the metabolic phenotypes observed in the
Nox2/ mice. Collectively, these findings implicate MMe
ATMs and their ability to exocytose their lysosomes to dead
adipocytes as a key determinant of adipose tissue remodeling
and health during prolonged obesity.
Figure 7. Ablating Nox2 in Myeloid Cells Is Sufficient to Produce Late-Onset Lipoatrophy, Hepatosteatosis, and Insulin Resistance
A comparison of the late-onset phenotypes in whole-animal, NOX2-deficient (global knockout [KO]), and myeloid cell-deficient (LysM-Cre KO) mice fed the HFD.
All parameters are plotted relative to the appropriate wild-type control (CTRL).
(A) Epididymal fat was stained with antibodies against PLIN2 (red, identifies adipocytes), MAC2 (green, identifiesmacrophages), and DAPI (blue, identifies nuclei).
Macrophages in crown-like structures (CLSs, arrow) were quantified by microscopy and standardized per unit area.
(B) Relative caspase-3 (CASP3) activity in epididymal fat.
(C) Relative epididymal fat mass.
(D) Relative levels of Hif1a (a hypoxia marker) and Tnfa and Il1b (inflammatory markers) in epididymal fat.
(E) H&E staining of the liver.
(F) Relative liver weight.
(G) Relative body weight gain.
(H and I) Relative fasting glucose (H) and insulin (I) levels. Data for the global control and KO mice are re-presented in modified form for comparative purposes.
Results are mean ± SEM; n = 5–10, *p < 0.05 Student’s t test. See also Figures S3, S4, and S7.
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The late-onset dead adipocyte accumulation was so extensive
inNox2/mice that they had less epididymal fat mass than their
wild-type counterparts despite being more obese, suggesting
that visceral fat could no longer store excess dietary nutrients.
This phenotype shares some similarities with lipodystrophy, in
which the inability to store nutrients in adipose tissue results in
ectopic fat accumulation in the liver and hepatosteatosis, which
in turn drives insulin resistance (Fiorenza et al., 2011). Nox2/
mice fed theHFD for 16weeks exhibited severe hepatosteatosis,
which was likely responsible for the hyperglycemia, hyperinsuli-
nemia, and insulin resistance at this time point (Cohen et al.,
2011; Shulman, 2014).
However, unlike lipodystrophy, Nox2/ mice did not exhibit
inherent defects in adipose tissue development or expansion.
Epididymal fat in Nox2/ mice fed the LFD was normal at
both time points. Furthermore, epididymal fat mass was higher
in Nox2/ mice fed the HFD for 8 weeks relative to wild-type
mice. Instead, Nox2/mice had a diminished capacity to main-
tain their epididymal fat during prolonged nutrient excess, when
adipose tissue hypoxia and adipocyte death were apparent, and
ATM-mediated dead adipocyte clearance was required.
The clearance of dead adipocytes poses two unique chal-
lenges for macrophages. First, because adipocytes are so
large, macrophages cannot phagocytose them. Instead, their
clearance relies on the formation of extracellular lysosomal
compartments between many macrophages and one adipocyte
(Haka et al., 2016), resulting in the formation of crown-like
structures. Second, adipocytes are predominantly composed
of TGs. Thus, during clearance, macrophages are exposed
to FFAs such as palmitate, which induce macrophage inflam-
mation (Kratz et al., 2014). For this reason, clearance of dead
adipocytes, unlike clearance of other dead cells (Fadok et al.,
1998), is an inflammation-propagating event. Crown-like struc-
tures have been positively correlated with inflammation in
adipose tissue of obese humans and mice (Lumeng et al.,
2007).
From this perspective, the MMe macrophage is well posi-
tioned to handle the unique challenges imposed by dead adipo-
cytes. FFAs released by dead adipocytes promote the MMe
macrophage phenotype and its associated upregulation of lyso-
somal exocytosis, lipid metabolism, and inflammation. Lyso-
somal exocytosis may drive FFA liberation to help clear the TG
droplet, which may be further enabled by the induction of lyso-
somal genes reported in ATMs from morbidly obese mice (Xu
et al., 2013). Increased expression of lipid metabolism genes
(i.e., ABCA1, CD36, and PLIN2) could help macrophages to pro-
ductively handle this excess fat, while inflammation could facili-
tate recruitment of additional macrophages to the crown-like
structure to assist in clearance.
Prolonged macrophage inflammation also carries its conse-
quences. Cytokines such as TNF-a promote damage to
metabolic organs and drive insulin resistance during obesity
(Hotamisligil et al., 1993) and our findings during early DIO pro-
vide further support for this widely accepted paradigm.
However, studies showed that themetabolic consequences of
this inflammation might not be as straightforward as this para-
digm suggests. For example, thermoneutral housing accelerated
the onset of adipose tissue inflammation but did not worsen the
metabolic phenotype (Tian et al., 2016). Similarly, ablating TNF-a
expression by adipocytes exacerbated obesity-associated insu-
lin resistance and hepatosteatosis (Wernstedt Asterholm et al.,
2014).
Our findings reinforce the emerging complex relationship
among inflammation, macrophages, and metabolic phenotypes
during DIO. We observed contradictory metabolic phenotypes
with the same anti-inflammatory perturbation (Nox2/) over
two time points during DIO. Previous studies with Nox2/
mice fed the HFD reported similar contradictory findings. One
study reported improvements in fasting glucose, glucose toler-
ance, and brain injury in Nox2/ mice fed a 60% HFD for
14 weeks (Pepping et al., 2013). Another study showed
increased adiposity due to hyperphagia and worsened insulin
resistance and hepatosteatosis in Nox2/ fed a 60% HFD for
18 weeks (Costford et al., 2014).
Although we cannot rule out the contribution of other NOX2-
driven mechanisms, the contradictory findings that we and
others report with Nox2/mice may be conceptualized by inte-
grating the beneficial and detrimental functions of ATMs through
a single MMe phenotype, whose impact on adipose tissue
biology andmetabolic phenotypes is determined by the duration
of high-fat feeding. Future experiments will be required to deter-




All animal studies were approved by the University of Chicago Institutional
Animal Care and Use Committee (ACUP 72209). Wild-type, Gp91/, Tlr2/,
Tlr4/, andMyd88/male mice on the C57BL/6 background are from Jack-
son Laboratory. For DIO studies, wild-type,Gp91/, Tlr2/, and Tlr4/mice
were placed on an LFD or HFD (45% fat, Research Diets, D12451) at 8 weeks
of age for up to 16 weeks.
Nox2fl/fl Mice
Nox2fl/fl mice were described (Sag et al., 2017) and were crossed with LysM-
cre knockin mice (Jackson Laboratory, 004781) to generate LysM-cre+/
Nox2fl/fl mice and littermate control Nox2fl/fl mice. See Supplemental Experi-
mental Procedures for genotyping details.
Differentiation and Activation of BMDMs
Murine BMDMswere differentiated from bonemarrow stem cells as previously
described (Kratz et al., 2014). For M1 activation, BMDMs were treated with
LPS (5 ng/mL) and IFNg (12 ng/mL) for 24 hr. For MMe activation, macro-
phages were treated with a combination of glucose (30 mM), insulin (10 nM),
and palmitate (0.4 mM) for 24 hr. Macrophages were also treated with media
conditioned by live 3T3-L1 adipocytes, apoptotic 3T3-L1 adipocytes, or
apoptotic neutrophils for 24 hr.
Macrophage Clearance of Apoptotic Adipocytes
Macrophage clearance of apoptotic adipocytes and subsequent accumula-
tion of lipids were performed as previously described (Haka et al., 2016).
See Supplemental Experimental Procedures for additional details.
ATM Isolation and Analysis
ATMs were isolated using anti-CD11b antibody coupled to magnetic beads as
previously described (Kratz et al., 2014), and purity was assessed by flow
cytometry. ATMs were interrogated by qRT-PCR, plasma membrane prote-
omics, and flow cytometry. A workflow for flow cytometric analysis of ATMs
is provided in the Supplemental Information (Figure S5).
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Plasma Membrane Proteomics
Plasma membrane proteins of BMDMs or ATMs were isolated and analyzed
by mass spectrometry as previously described (Becker et al., 2012). Proteins
were quantified by spectral counting and statistical significance was as-
sessed using a combination of the G test (G statistic) and t test (p value)
with correction for the false discovery rate as previously described (Heinecke
et al., 2010).
Plasma Measurements
Mice were fasted for 3 hr and serum insulin levels were measured by ELISA
(Millipore) and blood glucose levels were measured with a One Touch Ultra 2
glucometer (Lifescan). For glucose tolerance test (GTT), mice were fasted for
16 hr, injected with 1 g/kg glucose, and blood was collected at several time
points for the measurement of glucose and insulin levels. For insulin toler-
ance test (ITT), mice were fasted for 6 hr, injected with 0.5 mU/g insulin,
and blood was collected at several time points for the measurement of
glucose.
Adipose Tissue Measurements
Epididymal fat was stained with antibodies against murine MAC2 (Cedarlane)
and PLIN2 (Abcam), and fluorescence images were acquired using an
Olympus IX81 inverted wide fieldmicroscope. The number of crown-like struc-
tures in epididymal fat was by counting the number of adipocytes surrounded
by MAC-2 positive signal per unit area. Between 4 and 6 mice were used per
condition and 3 and 5 images were used per mouse. Epididymal fat caspase-3
activity wasmeasured using the Apo-ONE kit (Promega) according to theman-
ufacturer’s protocol.
Liver Measurements
Livers were perfused with 30 mL of PBS before excision, homogenized, and
TGs were measured using a TG quantification kit (Abcam) according to the
manufacturer’s protocol.
Statistics
Statistical significance was assessed using an unpaired, two-tailed, Student’s
t test. Replicate numbers for each experiment are indicated in the figure
legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.08.096.
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